Literature DB >> 3156004

Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium.

J P Arcoleo, I B Weinstein.   

Abstract

We have found that maximum stimulation (greater than 10-fold) of kinase activity of a bovine brain preparation of calcium- and phospholipid-dependent protein kinase (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) occurs in the presence of phospholipid, but in the absence of added Ca2+. In effect, nM concentrations of TPA substitute for mM concentrations of added Ca2+, and the two agents are not synergistic. Biologically active analogs of TPA such as phorbol-12,13-dibutyrate (PDBu), 12-O-hexadecanoyl-16-hydroxyphorbol-13-acetate (HHPA) or mezerein were also effective activators of PKC, as were the chemically unrelated tumor promoters teleocidin and aplysiatoxin, when tested at nM concentrations in the absence of added Ca2+. On the other hand, the biologically inactive compounds phorbol, 4-alpha-phorbol-12,13-didecanoate (4-alpha-PDD), HHPA-13,20-diacetate and 1,2-dihydro-20-deoxy-HHPA did not affect PKC activity in the absence or presence of Ca2+. Our results are consistent with a stereochemical model in which the hydrophilic domains of certain diterpenes, teleocidin and aplysiatoxin interact specifically with PKC apoenzyme, while their hydrophobic domains interact with phospholipid, thus forming an enzymatically active ternary complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156004     DOI: 10.1093/carcin/6.2.213

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  23 in total

Review 1.  The role of protein kinase C and its neuronal substrates dephosphin, B-50, and MARCKS in neurotransmitter release.

Authors:  P J Robinson
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

2.  Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.

Authors:  A M Jeffrey; R M Liskamp
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice.

Authors:  Okkyung Rho; Kaoru Kiguchi; Guiyu Jiang; John DiGiovanni
Journal:  Mol Carcinog       Date:  2013-09-20       Impact factor: 4.784

4.  Characterization of a specific form of protein kinase C overproduced by a C3H 10T1/2 cell line.

Authors:  S A Rotenberg; R S Krauss; C M Borner; I B Weinstein
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

5.  Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family.

Authors:  G M Housey; C A O'Brian; M D Johnson; P Kirschmeier; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Involvement of calcium-sensitive phospholipid-dependent protein kinase in control of acid secretion by isolated rat parietal cells.

Authors:  N G Anderson; P J Hanson
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

7.  Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.

Authors:  E Melloni; S Pontremoli; M Michetti; O Sacco; A G Cakiroglu; J F Jackson; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin.

Authors:  C A O'Brian; N E Ward; R M Liskamp; D B de Bont; L E Earnest; J H van Boom; D Fan
Journal:  Invest New Drugs       Date:  1991-05       Impact factor: 3.850

Review 9.  Biology of the protein kinase C family.

Authors:  C A O'Brian; N E Ward
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

10.  Activation of the human neutrophil nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase by protein kinase C.

Authors:  J A Cox; A Y Jeng; N A Sharkey; P M Blumberg; A I Tauber
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.